NBY
Price
$0.58
Change
-$0.01 (-1.69%)
Updated
Jun 6 closing price
Capitalization
3.43M
THAR
Price
$1.51
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
4.02M
Interact to see
Advertisement

NBY vs THAR

Header iconNBY vs THAR Comparison
Open Charts NBY vs THARBanner chart's image
NovaBay Pharmaceuticals
Price$0.58
Change-$0.01 (-1.69%)
Volume$20.5K
Capitalization3.43M
Tharimmune
Price$1.51
Change-$0.00 (-0.00%)
Volume$23.54K
Capitalization4.02M
NBY vs THAR Comparison Chart
Loading...
NBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NBY vs. THAR commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBY is a Buy and THAR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (NBY: $0.56 vs. THAR: $1.41)
Brand notoriety: NBY and THAR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NBY: 42% vs. THAR: 8%
Market capitalization -- NBY: $3.43M vs. THAR: $4.02M
NBY [@Biotechnology] is valued at $3.43M. THAR’s [@Biotechnology] market capitalization is $4.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NBY’s FA Score shows that 1 FA rating(s) are green whileTHAR’s FA Score has 1 green FA rating(s).

  • NBY’s FA Score: 1 green, 4 red.
  • THAR’s FA Score: 1 green, 4 red.
According to our system of comparison, both NBY and THAR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NBY’s TA Score shows that 5 TA indicator(s) are bullish while THAR’s TA Score has 5 bullish TA indicator(s).

  • NBY’s TA Score: 5 bullish, 4 bearish.
  • THAR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NBY is a better buy in the short-term than THAR.

Price Growth

NBY (@Biotechnology) experienced а +0.43% price change this week, while THAR (@Biotechnology) price change was +4.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
THAR($4.02M) has a higher market cap than NBY($3.43M). NBY has higher P/E ratio than THAR: NBY (0.02) vs THAR (0.02). NBY YTD gains are higher at: -6.406 vs. THAR (-30.315). NBY has higher annual earnings (EBITDA): -6.52M vs. THAR (-10.84M). THAR has more cash in the bank: 4.77M vs. NBY (776K). THAR has less debt than NBY: THAR (560K) vs NBY (1.26M). NBY has higher revenues than THAR: NBY (13.8M) vs THAR (0).
NBYTHARNBY / THAR
Capitalization3.43M4.02M85%
EBITDA-6.52M-10.84M60%
Gain YTD-6.406-30.31521%
P/E Ratio0.020.02108%
Revenue13.8M0-
Total Cash776K4.77M16%
Total Debt1.26M560K225%
FUNDAMENTALS RATINGS
NBY: Fundamental Ratings
NBY
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
58
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NBYTHAR
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
83%
Momentum
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
MACD
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
73%
Advances
ODDS (%)
Bullish Trend 21 days ago
82%
Bullish Trend 20 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 25 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 12 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
NBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

NBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, NBY has been closely correlated with CDTX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NBY jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBY
1D Price
Change %
NBY100%
-0.58%
CDTX - NBY
93%
Closely correlated
-5.46%
NCNA - NBY
93%
Closely correlated
-3.85%
WINT - NBY
92%
Closely correlated
+5.12%
SNPX - NBY
91%
Closely correlated
-10.74%
RNAC - NBY
91%
Closely correlated
+3.65%
More

THAR and

Correlation & Price change

A.I.dvisor indicates that over the last year, THAR has been closely correlated with CDTX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if THAR jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THAR
1D Price
Change %
THAR100%
-1.08%
CDTX - THAR
82%
Closely correlated
-5.46%
NBY - THAR
81%
Closely correlated
-0.58%
RNAC - THAR
81%
Closely correlated
+3.65%
NCNA - THAR
81%
Closely correlated
-3.85%
WINT - THAR
80%
Closely correlated
+5.12%
More